Relationship between antidepressants and suicide attempts: An analysis of the veterans health administration data sets

American Journal of Psychiatry

Volumn 164, Issue 7, 2007, Pages 1044-1049

  Gibbons, Robert D ^a   Brown, C Hendricks ^b   Hur, Kwan ^b   Marcus, Sue M ^b   Bhaumik, Dulal K ^b   Mann, J John ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; MIRTAZAPINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDE ATTEMPT; TREATMENT OUTCOME;

EID: 34547185949     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.7.1044     Document Type: Article

References (17)

1. Hammad TA: Review and evaluation of clinical data. Washington, DC, Food and Drug Administration, Aug 16, 2004 (http://www.fda.gov/ohrms/dockets/ac/04/ briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf)
2. Hammad TA, Laughren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63:332-339
3. Gibbons RD, Hur K, Bhaumik DK, Mann JJ: The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 2006; 163:1898-1904
4. Gibbons R, Hur K, Bhaumik D, Mann J: The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62:165-172
5. Olfson M, Shaffer D: Marcus SC, Greenberg T: Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003; 60:978-982
6. Gibbons RD, Brown CH, Hur K, Marcus S, Mann JJ, Erkens J, Herings R: Early evidence on the effects of the FDA black box warning on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry (in press)
7. Simon GE, Savarino J, Operskalski B, Wang PS: Suicide risk during antidepressant treatment. Am J Psychiatry 2006; 163:41-47
8. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR: Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs 2004; 18:1119-1132
9. Valuck RJ, Libby AM, Morrato EH, Gibbons RD, Brown CH, Oquendo MA: Antidepressant treatment and risk of suicide attempt by adults with major depressive disorder. Poster (abstract 87) presented at the annual meeting of the American College of Neuropsychopharmacology, Dec 11-15, 2005, Waikoloa, Hawaii
10. Khan A, Khan S, Kolts R, Brown WA: Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003; 160:790-792
11. Montgomery SA, Dunner DL, Dunbar GC: Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995; 5:5-13
12. Zaninelli R, Meister W: The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring. Pharmacopsychiatry 1997;30:9-20
13. Gunnell D, Saperia J, Ashby D: Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005; 330:385-389
14. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P: Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ 2005; 330:396-402
15. Jick H, Kaye JA, Jick SS: Antidepressants and the risk of suicidal behaviors, JAMA 2004; 292:338-343
16. Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D: Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005; 330:389-395
17. US Food and Drug Administration: Clinical review: relationship between antidepressant drugs and suicidality in adults. (http://www.fda.gov/ohrms/ dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf)